* Phibro Animal Health Corp PAHC.OQ PAHC.O is expected
to show
a rise in quarterly revenue when it reports results on August
30.
* The Teaneck New Jersey-based company is expected to
report a
1.3% increase in revenue to $258.55 million from $255.3 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Phibro Animal
Health Corp
is for earnings of 40 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Phibro
Animal
Health Corp is $17.5, above its last closing price of $14.98.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.33 0.34 0.29 Missed -13.4
Dec. 31 2023 0.30 0.30 0.34 Beat 12.2
Sep. 30 2022 0.27 0.27 0.21 Missed -20.9
Jun. 30 2022 0.38 0.38 0.26 Missed -32.1
Mar. 0.35 0.35 0.33 Missed -6.6
31 2022
Dec. 31 2021 0.32 0.33 0.37 Beat 13.3
Sep. 30 2021 0.27 0.29 0.25 Missed -14.8
Jun. 30 2021 0.32 0.31 0.32 Beat 2.5
This summary was machine generated August 28 at 20:51 GMT. All
figures in US dollars unless otherwise stated